domvanalimab,etrumadenant,zimberelimab
arcus biosciences,gilead
['lung', 'arc-7', '#gi', ' arcus ', 'gilead']
gilead and arcus report positive interim results from arc-7 study, showing improvement in non-small cell lung cancer patients. #gild #rcus #asco #positive 
Real-time news analysis & sentiment scoring for the stocks in the Nasdaq100
Powered by @streetbeat_com of @SP500Tracker
Disclosure: https://t.co/ixCFGXlG3M